Valiance is a leading global Life Sciences investor focused on addressing the unmet needs of a growing and ageing population, delivering strong upside for our investors whilst also generating significant health economics and improving people’s lives.
We make an impact through carefully chosen investment themes in areas where we have significant investment experience, with a principal focus on MedTech and Digital and Nutritional Health. The companies we invest in help to develop life-changing technology that has significant benefits to patients as well as society as a whole.
We complement the insight of our team with that of our established network to identify the right opportunities and make informed investment decisions. Drawing on the team’s vast experience, Valiance supports successful businesses, assisting them through the next stages of their growth.
Our focus is on miniaturisation within the MedTech sector, which is developing minimally invasive solutions to address many of the most common health issues faced by ageing patients.
In areas where surgery or medicine has been unable to help, particularly in the case of general wear and tear, MedTech is able to provide breakthrough alternatives, and is increasingly applicable for treatment of younger patients.
Digital & Nutritional Health
We focus on the opportunities that exist in connections between smart medical devices and software applications, which together can improve therapy and enable remote monitoring, thus keeping patients out of the highly infectious and costly hospital environment for longer. We in particular seek technologies that have the potential to change patient behaviour. This is especially relevant given the simultaneous need to improve the health and nutritional intake of a growing population whilst addressing inherent dietary issues such as obesity.
To learn more about Valiance, our portfolio and investment opportunities, please visit our website.
Location: United Kingdom, England, Westminster